MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions.

Autor: Zheng Y; School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Jinghai, Tianjin, China., Zhang X; School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Jinghai, Tianjin, China., Wang Z; School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Jinghai, Tianjin, China., Zhang R; School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Jinghai, Tianjin, China., Wei H; School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Jinghai, Tianjin, China., Yan X; School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Jinghai, Tianjin, China., Jiang X; School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Jinghai, Tianjin, China., Yang L; School of Medicial Technology, Tianjin University of Traditional Chinese Medicine, Tianjin, Jinghai, China.

Publikováno v: Archiv der Pharmazie [Arch Pharm (Weinheim)] 2024 Nov; Vol. 357 (11), pp. e2400459. Date of Electronic Publication: 2024 Aug 23.